Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David M Gershenson
Selumetinib in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary or Peritoneum: An Open-Label, Single-Arm, Phase 2 Study
The Lancet Oncology
Oncology
PAX2 Expression in Low Malignant Potential Ovarian Tumors and Low-Grade Ovarian Serous Carcinomas
Modern Pathology
Forensic Medicine
Pathology
Related publications
Once-Weekly Ofatumumab in Untreated or Relapsed Waldenström's Macroglobulinaemia: An Open-Label, Single-Arm, Phase 2 Study
The Lancet Haematology
Hematology
Mocetinostat for Relapsed Classical Hodgkin's Lymphoma: An Open-Label, Single-Arm, Phase 2 Trial
The Lancet Oncology
Oncology
Low Frequency of BRAF and KRAS Mutations in Chinese Patients With Low-Grade Serous Carcinoma of the Ovary
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
Invasion Patterns of Metastatic High-Grade Serous Carcinoma of Ovary or Fallopian Tube Associated With BRCA Deficiency
Modern Pathology
Forensic Medicine
Pathology
Expression Profiling of Serous Low Malignant Potential, Low-Grade, and High-Grade Tumors of the Ovary
Cancer Research
Cancer Research
Oncology
Low Grade Serous Carcinoma of the Testis: A Case Report
Pathology
Forensic Medicine
Pathology
P2.01-02 Osimertinib for EGFR-Positive Advanced NSCLC With Brain Metastases: Preliminary Analysis of an Open-Label, Two-Arm, Phase 2 Study
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Phase I, Open-Label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Efficacy, Safety and Pharmacokinetics of Subcutaneous Azacitidine in Chinese Patients With Higher Risk Myelodysplastic Syndromes: Results From a Multicenter, Single-Arm, Open-Label Phase 2 Study
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
